Onconova Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Penns Trl, Newtown, Pennsylvania, 189...Phone Number
(267) 759-3680Website
www.onconova.comRevenue
<$5 MillionStock Symbol
ONTXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Onconova Therapeutics
Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel drugs to treat cancer. Onconova has a pipeline of proprietary targeted agents designed to work against specific cellular pathways that are important in cancer cells. Clinical trials with the Company's compound rigosertib are aimed at what the Company believes are unmet medical needs of patients with cancer. Onconova has conducted trials with two other research compounds, and has a pre-clinical program with a CDK4/6 and ARK5 inhibitor, ON 123300.Explore more
Onconova Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Onconova Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Onconova Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Onconova Therapeutics
Product Launch: Get notified when Onconova Therapeutics launches new products
Funding: Get notified immidiatlly once Onconova Therapeutics has new funding data
Click to see if Onconova Therapeutics had a recent Job posting/layoffs
Check if Onconova Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Onconova Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Onconova Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Onconova Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Onconova Therapeutics
Compare insights from companies similar to Onconova Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Onconova Therapeutics
<$5M
11-50
Public
$77.5M
1998
RW
Ric WoodmanChief Medical Officer & Senior VP, Research & Development
Company Profile Activity
Activity Insights
Onconova Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Onconova Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Onconova Therapeutics.
Onconova Therapeutics financials insights
Gather financial insights about Onconova Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$77.5M
Onconova Therapeutics Tech Stack
A closer look at the technologies used by Onconova Therapeutics
See more technologies
Most Recent Scoops
Earnings
Accessibility
Earnings
Earnings
Financial Planning, Financial Systems, Financial Reporting, Financial Operations, Financial Strategy, Financial Transactions, Financing & Debt, Operations
Earnings
Seeking Replacement, Partnership, Business Intelligence, Business Development, Share Placement, Business Finance, Business Insurance, Finance
Earnings
Engineering, Clinical Systems, Industrial Engineering, Clinical Operations, Operations
Onconova Therapeutics News & Media
Snell & Wilmer Advises Biotechnology Company Trawsfynydd Therapeutics, Inc. in Merger ...
Snell & Wilmer is one of the largest law firms in the western United States.Onconova Therapeutics, Inc. (ONTX) Q3 2023 Earnings Call Transcript
Onconova Therapeutics, Inc. (NASDAQ:NASDAQ:ONTX) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci...Onconova Therapeutics, Inc. (ONTX) Q2 2023 Earnings Call Transcript
Onconova Therapeutics, Inc. (NASDAQ:NASDAQ:ONTX) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, IRDr.Onconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma
Narazaciclib demonstrated significant synergistic anti-cancer activity in multiple in vivo models of mantle cell lymphoma (MCL) when combined with ibrutinib, the current standard-of-care Narazaciclib demonstrated significant synergistic anti-cancer activity in multiple in vivo models of mantle cell lymphoma (MCL) when combined with ibrutinib, the current standard-of-care
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Onconova Therapeutics
Sign Up For FreeTo access detailed company insights
Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel drugs to treat cancer. Onconova has a pipeline of proprietary targeted agents designed to work against specific cellular pathways that are important in cancer cells. Clinical trials with the Company's compound rigosertib are aimed at what the Company be... Read More
